Aiolos Cloud

Aiolos Cloud company information, Employees & Contact Information

Explore related pages

Related company profiles:

Aiolos Cloud Solutions is a venture funded technology startup with capabilities across: i) Advanced Cloud Services (Digital Twin, Computer Vision, Migration, Development, Modernization, Optimization across public clouds. ii) Engineering using Open Source technologies (node.js, react.js, python, php, ruby on rails, java, mongodb, flutter, android, ios, etc.) & CMS development (wordpress, drupal, joomla, headless cms, etc.) iii) Product development powered by UX design & UI engineering Centers of Excellence iv) QA & project management. Our clients include Fortune 500s (Starbucks, Whirlpool Corp, MasterCard, Worldline Global, Deloitte, Citicorp, Reliance Jio among others). Some of the projects that we have worked on are: - A tap-on-phone, contactless, mobile-only payments solution that services 20M+ merchants across India. - An AI-powered insights and investment advisory platform that ensures that you are on top of market trends by deploying machine learning algorithms rendered using unique visualization and graphs. - An RFID-powered urban mobility platform that enables seamless passage of vehicles through 850+ gated plazas.

Company Details

Employees
15
Address
Mumbai, In
Industry
It Services And It Consulting
NAICS
Computer Systems Design and Related Services
Other Computer Related Services
Keywords
IT Consulting.
HQ
Mumbai
Looking for a particular Aiolos Cloud employee's phone or email?

Aiolos Cloud Questions

News

PBK/TOPK mediates Ikaros, Aiolos and CTCF displacement from mitotic chromosomes and alters chromatin accessibility at selected C2H2-zinc finger protein binding sites - Nature

PBK/TOPK mediates Ikaros, Aiolos and CTCF displacement from mitotic chromosomes and alters chromatin accessibility at selected C2H2-zinc finger protein binding sites Nature

Greek Student Team Aiolos NTUA Takes Global Wind Turbine Gold - tovima.com

Greek Student Team Aiolos NTUA Takes Global Wind Turbine Gold tovima.com

GSK enters agreement to acquire Aiolos Bio - GSK

GSK enters agreement to acquire Aiolos Bio GSK

C4 takes the Ikaros/Aiolos battle to Bristol | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

C4 takes the Ikaros/Aiolos battle to Bristol | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Disease-associated AIOLOS variants lead to immune deficiency/dysregulation by haploinsufficiency and redefine AIOLOS functional domains - JCI.org

Disease-associated AIOLOS variants lead to immune deficiency/dysregulation by haploinsufficiency and redefine AIOLOS functional domains JCI.org

Aiolos Bio raises $245M on prospect of better asthma drug - BioPharma Dive

Aiolos Bio raises $245M on prospect of better asthma drug BioPharma Dive

Aiolos: a molecular guardian of type 2 innate immune cell residency and response - ScienceDirect.com

Aiolos: a molecular guardian of type 2 innate immune cell residency and response ScienceDirect.com

The Week’s 10 Biggest Funding Rounds: Anthropic Rules With $500M Round; Aiolos Bio Nabs Large Raise - Crunchbase News

The Week’s 10 Biggest Funding Rounds: Anthropic Rules With $500M Round; Aiolos Bio Nabs Large Raise Crunchbase News

Obesity-fighting MedTech launches with £334m investment - BusinessCloud

Obesity-fighting MedTech launches with £334m investment BusinessCloud

GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug - statnews.com

GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug statnews.com

GSK concludes Aiolos Bio acquisition for up to $1.4bn - Pharmaceutical Technology

GSK concludes Aiolos Bio acquisition for up to $1.4bn Pharmaceutical Technology

GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal - Reuters

GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal Reuters

AIOLOS Variants Causing Immunodeficiency in Human and Mice - Frontiers

AIOLOS Variants Causing Immunodeficiency in Human and Mice Frontiers

GSK completes acquisition of Aiolos Bio - GSK

GSK completes acquisition of Aiolos Bio GSK

IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development - Nature

IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development Nature

GSK to buy asthma drug startup Aiolos for $1B - BioPharma Dive

GSK to buy asthma drug startup Aiolos for $1B BioPharma Dive

The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes - Nature

The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes Nature

T cell cytotoxic programming via reciprocal regulation of T - Nature

T cell cytotoxic programming via reciprocal regulation of T Nature

A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS - Nature

A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS Nature

GSK, moving fast to buy Aiolos, pays $1B to challenge Amgen, AstraZeneca for asthma market - Fierce Biotech

GSK, moving fast to buy Aiolos, pays $1B to challenge Amgen, AstraZeneca for asthma market Fierce Biotech

Aiolos regulates eosinophil migration into tissues - Nature

Aiolos regulates eosinophil migration into tissues Nature

Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med - Fierce Biotech

Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med Fierce Biotech

Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody - Business Wire

Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody Business Wire

Aiolos team reunites with $411M for new biotech with obesity drugs from China - Endpoints News

Aiolos team reunites with $411M for new biotech with obesity drugs from China Endpoints News

Aiolos Bio launches with $245M Series A, chasing one of asthma’s hottest targets - Endpoints News

Aiolos Bio launches with $245M Series A, chasing one of asthma’s hottest targets Endpoints News

GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline - BioSpace

GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline BioSpace

Aiolos Bio debuts with $245 million financing - The Pharma Letter

Aiolos Bio debuts with $245 million financing The Pharma Letter

Aiolos Bio Launches With $245M As Asthma-Focused Funding Accelerates - Crunchbase News

Aiolos Bio Launches With $245M As Asthma-Focused Funding Accelerates Crunchbase News

GSK completes acquisition of Aiolos Bio for up to $1.4 bln - Reuters

GSK completes acquisition of Aiolos Bio for up to $1.4 bln Reuters

Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity - Nature

Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity Nature

Aiolos Promotes Anchorage Independence by Silencing p66Shc Transcription in Cancer Cells - ScienceDirect.com

Aiolos Promotes Anchorage Independence by Silencing p66Shc Transcription in Cancer Cells ScienceDirect.com

GSK to expand respiratory pipeline with $1.4bn Aiolos Bio acquisition - PMLiVE

GSK to expand respiratory pipeline with $1.4bn Aiolos Bio acquisition PMLiVE

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos - ACS Publications

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos ACS Publications

Immortals Fenyx Rising guide: Aiolos’s Strength Vault of Tartaros walkthrough and puzzle solutions - Polygon

Immortals Fenyx Rising guide: Aiolos’s Strength Vault of Tartaros walkthrough and puzzle solutions Polygon

Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4 | Blood Cancer Journal - Nature

Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4 | Blood Cancer Journal Nature

Immortals Fenyx Rising Blurry Vision Guide - How To Open The Red Door And Get Aiolos' Jar In The One-Eyed Giant - TheGamer

Immortals Fenyx Rising Blurry Vision Guide - How To Open The Red Door And Get Aiolos' Jar In The One-Eyed Giant TheGamer

London: GSK to pay up to US$1.4bn for Aiolos Bio - Investors in Healthcare

London: GSK to pay up to US$1.4bn for Aiolos Bio Investors in Healthcare

Astro Toy - Myth Cloth EX Sagittarius Aiolos - Anime News Network

Astro Toy - Myth Cloth EX Sagittarius Aiolos Anime News Network

Top Aiolos Cloud Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant